Ovid Therapeutics Inc. (OVID) Form 8-K Material Events
Ovid Therapeutics Inc. (OVID) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OVID
CIK: 1636651
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJoseph Epstein
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-08-24 | — | 144 Filing | 0001311404-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001311404-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097342 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000926 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001580642-26-005303 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003432 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001011438-26-000510 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001628280-26-056498 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-11 | 8-K | 0001628280-26-056497 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002922 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 Filing | 0001779359-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-07-08 | 2026-07-06 | 3 Filing | 0001779359-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001623632-26-000990 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-05 | 8-K | 0001628280-26-047584 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0002138163-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-06-17 | 2026-06-15 | 3 Filing | 0002138163-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001628280-26-042396 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-05-29 | 8-K | 0001628280-26-040038 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003481 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001580642-26-003200 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000919574-26-003209 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001193125-26-225184 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001256153-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001011438-26-000317 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001628280-26-033864 | View SEC Doc Filr Page |